Literature DB >> 19942992

Recommendations of the Latin American Thyroid Society on diagnosis and management of differentiated thyroid cancer.

Fabián Pitoia1, Laura Ward, Nelson Wohllk, Celso Friguglietti, Eduardo Tomimori, Alicia Gauna, Rosalinda Camargo, Mario Vaisman, Rubén Harach, Fernando Munizaga, Sandro Corigliano, Eduardo Pretell, Hugo Niepomniszcze.   

Abstract

The aims of these recommendations were to develop clinical guidelines for evaluation and management of patients with differentiated thyroid cancer applicable to Latin American countries. The panel was composed by 13 members of the Latin American Thyroid Society (LATS) involved with research and management of thyroid cancer from different medical centers in Latin America. The recommendations were produced on the basis of the expert opinion of the panel with use of principles of Evidence-Based Medicine. Following a group meeting, a first draft based on evidences and the expert opinions of the panel was elaborated and, later, circulated among panel members, for further revision. After, this document was submitted to the LATS members, for commentaries and considerations, and, finally, revised and refined by the authors. The final recommendations presented in this paper represent the state of the art on management of differentiated thyroid cancer applied to all Latin American countries.

Entities:  

Mesh:

Year:  2009        PMID: 19942992     DOI: 10.1590/s0004-27302009000700014

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  31 in total

Review 1.  Impact of prophylactic central neck dissection on oncologic outcomes of papillary thyroid carcinoma: a review.

Authors:  Elisabeth Mamelle; Isabelle Borget; Sophie Leboulleux; Haïtham Mirghani; Carlos Suárez; Phillip K Pellitteri; Ashok R Shaha; Marc Hamoir; K Thomas Robbins; Avi Khafif; Juan P Rodrigo; Carl E Silver; Alessandra Rinaldo; Alfio Ferlito; Dana M Hartl
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-11       Impact factor: 2.503

2.  One should not just read what one believes: the nearly irresolvable issue of producing truly objective, evidence-based guidelines for the management of differentiated thyroid cancer.

Authors:  Markus Dietlein; F A Verburg; M Luster; C Reiners; F Pitoia; H Schicha
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-05       Impact factor: 9.236

3.  The "broken chair" in patients with differentiated thyroid cancer.

Authors:  Amanda La Greca; Fabián Pitoia; R Michael Tuttle
Journal:  Endocrine       Date:  2017-06-14       Impact factor: 3.633

4.  Surgical approach and radioactive iodine therapy for small well-differentiated thyroid cancer.

Authors:  D P Momesso; F Vaisman; L S C Caminha; C H C N Pessoa; R Corbo; M Vaisman
Journal:  J Endocrinol Invest       Date:  2014-01-08       Impact factor: 4.256

Review 5.  Optimal differentiated thyroid cancer management in the elderly.

Authors:  Donald S A McLeod; Kelly Carruthers; Dev A S Kevat
Journal:  Drugs Aging       Date:  2015-04       Impact factor: 3.923

Review 6.  Nodal metastases in thyroid cancer: prognostic implications and management.

Authors:  Laura Y Wang; Ian Ganly
Journal:  Future Oncol       Date:  2016-03-07       Impact factor: 3.404

7.  Recombinant human thyroid-stimulating hormone-aided remnant ablation achieves a response to treatment comparable to that with thyroid hormone withdrawal in patients with clinically relevant lymph node metastases.

Authors:  Fabián Pitoia; Erika Abelleira; Graciela Cross
Journal:  Eur Thyroid J       Date:  2014-12-06

Review 8.  Radioiodine Ablation following Thyroidectomy for Differentiated Thyroid Cancer: Literature Review of Utility, Dose, and Toxicity.

Authors:  Nicholas S Andresen; John M Buatti; Hamed H Tewfik; Nitin A Pagedar; Carryn M Anderson; John M Watkins
Journal:  Eur Thyroid J       Date:  2017-03-23

9.  Biochemical persistence in thyroid cancer: is there anything to worry about?

Authors:  Fabián Pitoia; Pitoia Fabián; Erika Abelleira; Abelleira Erika; Hernán Tala; Tala Hernán; Fernanda Bueno; Bueno Fernanda; Carolina Urciuoli; Urciuoli Carolina; Graciela Cross; Cross Graciela
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

10.  Chromatin changes in papillary thyroid carcinomas may predict patient outcome.

Authors:  R C Ferreira; L L Cunha; P S Matos; R L Adam; F Soares; J Vassallo; L S Ward
Journal:  Cell Oncol (Dordr)       Date:  2012-12-05       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.